I think the gross margins would disappoint although I would expect this to improve as more masks are sold off the back of the increase in devices and supply chains coming back to normal. Hopefully the market focused on quarterly results throws up an opportunity to buy more under $30 for investors that look beyond short term results.
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-3
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$32.91 |
Change
-0.050(0.15%) |
Mkt cap ! $20.43B | |||
| Open | High | Low | Value | Volume |
| $33.08 | $33.27 | $32.84 | $53.41M | 1.619M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2687 | $32.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.00 | 1249 | 35 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$32.97 |
Change
-0.050 ( 0.15 %) |
||||
| Open | High | Low | Volume | ||
| $33.09 | $33.25 | $32.85 | 298626 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| RMD (ASX) Chart |